JILL WEIDA: Open Payments
NPI 1982009825 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 28 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $228 |
| Eisai Inc. | 5 | $141 |
| GlaxoSmithKline, LLC. | 3 | $83 |
| Daiichi Sankyo Inc. | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| ABBVIE INC. | 2 | $50 |
| Corcept Therapeutics | 2 | $50 |
| Verastem, Inc. | 1 | $31 |
| ACCORD HEALTHCARE, INC. | 1 | $17 |
Products named: KEYTRUDA, Lenvima, JEMPERLI, LYNPARZA, Enhertu, ELAHERE, Korlym, AVMAPKI FAKZYNJA CO-PACK.
Industry payments across TN — which companies pay providers there.
